The Effects of TMS on Memory-consolidation in Human Primary Visual Cortex

This study has been withdrawn prior to enrollment.
(Due to administrative issues, the study was withdrawn.)
Information provided by:
Sheba Medical Center Identifier:
First received: May 29, 2007
Last updated: August 28, 2011
Last verified: August 2011

Rapid Transcranial Magnetic Stimulation will be used in order to examine whether the human primary visual cortex is essential to visual memory consolidation.

Condition Intervention
Device: rTMS

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: The Effects of Transcranial Magnetic Stimulation of the Brain on Memory-consolidation in Human Primary Visual Cortex

Resource links provided by NLM:

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 0
Study Start Date: May 2005
Estimated Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: rTMS
    repetitive transcranial meagnetic stimulation of the brain

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy
  • Right handed

Exclusion Criteria:

  • Active/past neurological/psychiatric disorder
  • Personal/first-degree history of seizures
  • Cardio-vascular disorder or disease including hypertension chronic use of medication
  • Metal/electronic device implant
  • Pregnancy
  Contacts and Locations
Please refer to this study by its identifier: NCT00480012

Sponsors and Collaborators
Sheba Medical Center
Principal Investigator: Revital Amiaz, MD Sheba Medical Center
  More Information

No publications provided

Responsible Party: Amiaz Revital, MD - Senior Psychiatrist, Sheba Medical Center Identifier: NCT00480012     History of Changes
Other Study ID Numbers: SHEBA-04-3437-RA-CTIL
Study First Received: May 29, 2007
Last Updated: August 28, 2011
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
healthy subjects processed this record on April 15, 2014